Skip to main content

Peer Review reports

From: A randomized, 29-day, dose-ranging, efficacy and safety study of daprodustat, administered three times weekly in patients with anemia on hemodialysis

Original Submission
3 May 2019 Submitted Original manuscript
1 Jul 2019 Reviewed Reviewer Report - Jay Wish
2 Jul 2019 Reviewed Reviewer Report - Tetsuhiro Tanaka
30 Jul 2019 Author responded Author comments - Christine Bailey
Resubmission - Version 2
30 Jul 2019 Submitted Manuscript version 2
4 Aug 2019 Reviewed Reviewer Report - Jay Wish
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
29 Aug 2019 Editorially accepted
16 Oct 2019 Article published 10.1186/s12882-019-1547-z

You can find further information about peer review here.

Back to article page